Doctor’s Lounge: Empagliflozin Ups β Cell Function in Impaired Fasting Glucose

Empagliflozin is associated with improved beta cell function in subjects with impaired fasting glucose, according to a study published online June 13 in Diabetes.

Read the full story at the Doctor’s Lounge



Share This Article!
Article Categories: In the News